The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Gomez, Christopher M.
Item TypeName
Academic Article A transgenic mouse model of the slow-channel syndrome.
Academic Article Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.
Academic Article Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome.
Academic Article Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome.
Academic Article Focal caspase activation underlies the endplate myopathy in slow-channel syndrome.
Academic Article Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model.
Academic Article Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome.
Academic Article Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome.
Academic Article A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome.
Academic Article Novel beta subunit mutation causes a slow-channel syndrome by enhancing activation and decreasing the rate of agonist dissociation.
Academic Article A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome.
Academic Article Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
Academic Article Inositol-1,4,5-triphosphate receptors mediate activity-induced synaptic Ca2+ signals in muscle fibers and Ca2+ overload in slow-channel syndrome.
Academic Article Macroscopic properties of spontaneous mutations in slow-channel syndrome: correlation by domain and disease severity.
Academic Article Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome.
Search Criteria
  • Potassium Chloride